High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumab-induced cardiotoxicity in HER2-positive early-stage breast cancer: a pilot study

Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients

(2011) Heloisa Sawaya et al.   AMERICAN JOURNAL OF CARDIOLOGY

Exploratory analysis of cardiac biomarkers in women with normal cardiac function receiving trastuzumab for breast cancer

(2011) Shom Goel et al.   Asia-Pacific Journal of Clinical Oncology

Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib

(2011) P. G. Morris et al.   CLINICAL CANCER RESEARCH

The Utility of Cardiac Biomarkers, Tissue Velocity and Strain Imaging, and Cardiac Magnetic Resonance Imaging in Predicting Early Left Ventricular Dysfunction in Patients With Human Epidermal Growth Factor Receptor II–Positive Breast Cancer Treated With Adjuvant Trastuzumab Therapy

(2011) Nazanin Fallah-Rad et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Left Ventricular Function and C-Reactive Protein Levels in Acute Myocardial Infarction

(2010) Adelaide M. Arruda-Olson et al.   AMERICAN JOURNAL OF CARDIOLOGY

Efficacy and cardiac safety of adjuvant trastuzumab-based chemotherapy regimens for HER2-positive early breast cancer

(2010) R. B. Costa et al.   ANNALS OF ONCOLOGY

The cardiac safety of trastuzumab in the treatment of breast cancer

(2010) A Jo Chien et al.   Expert Opinion On Drug Safety

Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation

(2010) Daniela Cardinale et al.   JOURNAL OF CLINICAL ONCOLOGY

Usefulness of C-Reactive Protein and Left Ventricular Diastolic Performance for Prognosis in Patients With Left Ventricular Systolic Heart Failure

(2008) W.H. Wilson Tang et al.   AMERICAN JOURNAL OF CARDIOLOGY

Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease

(2008) Ramón Arroyo-Espliguero et al.   ATHEROSCLEROSIS

Competing Causes of Death From a Randomized Trial of Extended Adjuvant Endocrine Therapy for Breast Cancer

(2008) J.-A. W. Chapman et al.   JNCI-Journal of the National Cancer Institute